Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 95

1.

Future long-term trials of postmenopausal hormone replacement therapy - what is possible and what is the optimal protocol and regimen?

Purbrick B, Stranks K, Sum C, MacLennan AH.

Climacteric. 2012 Jun;15(3):288-93. doi: 10.3109/13697137.2011.635825.

PMID:
22612617
2.
3.

Have we come full circle - or moved forward? The Women's Health Initiative 10 years on.

Langer RD, Manson JE, Allison MA.

Climacteric. 2012 Jun;15(3):206-12. doi: 10.3109/13697137.2012.666916. Review.

PMID:
22612605
4.

Climacteric medicine: European Menopause and Andropause Society (EMAS) 2004/2005 position statements on peri- and postmenopausal hormone replacement therapy.

Skouby SO, Al-Azzawi F, Barlow D, Calaf-Alsina Erdogan Ertüngealp J, Gompel A, Graziottin A, Hudita D, Pines A, Rozenberg S, Samsioe G, Stevenson JC; European Menopause and Andropause Society.

Maturitas. 2005 May 16;51(1):8-14.

PMID:
15883103
5.
7.

Benefits of hormone replacement therapy in postmenopausal women.

Canderelli R, Leccesse LA, Miller NL, Unruh Davidson J.

J Am Acad Nurse Pract. 2007 Dec;19(12):635-41. Review.

PMID:
18042129
8.

Hormone replacement therapy in postmenopausal women.

Yasui T, Uemura H, Takikawa M, Irahara M.

J Med Invest. 2003 Aug;50(3-4):136-45. Review.

PMID:
13678382
9.

Perspectives on the Women's Health Initiative trial of hormone replacement therapy.

Grimes DA, Lobo RA.

Obstet Gynecol. 2002 Dec;100(6):1344-53. Review.

PMID:
12468183
10.

Turbulent times for hormone replacement therapy: is there a way out?

Verhaeghe J.

Gynecol Obstet Invest. 2003;56(1):43-50. Epub 2003 Jul 22. Review.

PMID:
12876424
11.

The role of selective estrogen receptor modulators (SERMs) in postmenopausal health.

Draper MW.

Ann N Y Acad Sci. 2003 Nov;997:373-7. Review.

PMID:
14644844
12.

New products and regimens (since 2003).

Panay N.

Climacteric. 2007 Oct;10 Suppl 2:109-14. Review.

PMID:
17882685
13.

Comparative cardiovascular effects of different progestins in menopause.

Rosano GM, Fini M.

Int J Fertil Womens Med. 2001 Sep-Oct;46(5):248-56. Review.

PMID:
11720197
14.

Is the WHI relevant to HRT started in the perimenopause?

Harman SM, Brinton EA, Clarkson T, Heward CB, Hecht HS, Karas RH, Judelson DR, Naftolin F.

Endocrine. 2004 Aug;24(3):195-202.

PMID:
15542885
16.

Perspectives in hormone replacement therapy.

Kenemans P, van Unnik GA, Mijatovic V, van der Mooren MJ.

Maturitas. 2001 Jun 15;38 Suppl 1:S41-8. Review.

PMID:
11390123
17.

Postmenopausal hormone therapy: lessons from observational and randomized studies.

Rosano GM, Vitale C, Lello S.

Endocrine. 2004 Aug;24(3):251-4. Review.

PMID:
15542893
19.

Postmenopausal hormone therapy: cardiovascular risks.

[No authors listed]

Prescrire Int. 2003 Apr;12(64):65-9.

PMID:
12674130
20.

A comparative review of the risks and benefits of hormone replacement therapy regimens.

Warren MP.

Am J Obstet Gynecol. 2004 Apr;190(4):1141-67. Review.

PMID:
15118656

Supplemental Content

Support Center